Page 362 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 362

318        SECTION III    CARDIOvASCuLAR  ``CARdIOvASCulAR—PHARMACOlOGY                                                                                     CARDIOvASCuLAR  ``CARdIOvASCulAR—PHARMACOlOGY





               Calcium channel       Amlodipine, clevidipine, nicardipine, nifedipine, nimodipine (dihydropyridines, act on vascular
               blockers                smooth muscle); diltiazem, verapamil (non-dihydropyridines, act on heart).

                MECHANISM            Block voltage-dependent L-type calcium channels of cardiac and smooth muscle Ž  muscle
                                       contractility.
                                     Vascular smooth muscle—amlodipine = nifedipine > diltiazem > verapamil.
                                     Heart—verapamil > diltiazem > amlodipine = nifedipine (verapamil = ventricle).
                ClINICAl uSE         Dihydropyridines (except nimodipine): hypertension, angina (including vasospastic type), Raynaud
                                      phenomenon.
                                     Nimodipine: subarachnoid hemorrhage (prevents cerebral vasospasm).
                                     Nicardipine, clevidipine: hypertensive urgency or emergency.
                                     Non-dihydropyridines: hypertension, angina, atrial fibrillation/flutter.
                AdvERSE EFFECTS      Gingival hyperplasia.
                                     Dihydropyridine: peripheral edema, flushing, dizziness.
                                     Non-dihydropyridine: cardiac depression, AV block, hyperprolactinemia (verapamil), constipation.



               Hydralazine
                MECHANISM             cGMP Ž smooth muscle relaxation. Vasodilates arterioles > veins; afterload reduction.

                ClINICAl uSE         Severe hypertension (particularly acute), HF (with organic nitrate). Safe to use during pregnancy.
                                      Frequently coadministered with a β-blocker to prevent reflex tachycardia.
                AdvERSE EFFECTS      Compensatory tachycardia (contraindicated in angina/CAD), fluid retention, headache, angina,
                                      drug-induced lupus.


               Hypertensive          Treat with labetalol, clevidipine, fenoldopam, nicardipine, nitroprusside.
               emergency
                Nitroprusside        Short acting vasodilator (arteries = veins);  cGMP via direct release of NO. Can cause cyanide
                                      toxicity (releases cyanide).
                Fenoldopam           Dopamine D 1  receptor agonist—coronary, peripheral, renal, and splanchnic vasodilation.  BP,
                                       natriuresis. Also used postoperatively as an antihypertensive. Can cause hypotension and
                                      tachycardia.



               Nitrates              Nitroglycerin, isosorbide dinitrate, isosorbide mononitrate.
                MECHANISM            Vasodilate by  NO in vascular smooth muscle Ž  in cGMP and smooth muscle relaxation.
                                      Dilate veins >> arteries.  preload.
                ClINICAl uSE         Angina, acute coronary syndrome, pulmonary edema.
                AdvERSE EFFECTS      Reflex tachycardia (treat with β-blockers), hypotension, flushing, headache, “Monday disease” in
                                      industrial exposure: development of tolerance for the vasodilating action during the work week
                                      and loss of tolerance over the weekend Ž tachycardia, dizziness, headache upon reexposure.
                                      Contraindicated in right ventricular infarction, hypertrophic cardiomyopathy, and with
                                      concurrent PDE-5 inhibitor use.



















          FAS1_2019_07-Cardio.indd   318                                                                                11/7/19   4:24 PM
   357   358   359   360   361   362   363   364   365   366   367